Problems Treatment Type II Diabetes Mellitus Patients with PCNE 9.1 and Correlation to Therapy Outcomes
DOI:
https://doi.org/10.59890/ijgsr.v1i3.805Keywords:
T2DM, DRP'S, PCNE 9.1, Length Of Stay, Outcome TreatmentAbstract
Drug-Related Problems in T2DM patients based on patient therapy patterns with or without comorbidities. DRP analysis is based on PCNE 9.1 guidelines analysing the domains causing problems in treatment, then bivariate data analysis (chi-square) to test the relationship between results and DRP type and continued with a multivariate test to see the connection between results and DRP type. The research results were three related variables related to DRPs and LOS, 15 cases of errors in drug selection, and eight instances of errors of treatment duration due to the absence of initiation of maintenance doses. Dose selection errors occurred in year 16, caused by an amount too low. It is recommended to research analysis prospectively so that the status of DRPs can be determined.
References
Ahmed, K. O., Muddather, H. F., & Yousef, B. A. (2021). Pharmaceutical Care Network Europe (PCNE) Drug-Related Problems Classification Version 9.1: First Implementation in Sudan. Journal of Pharmaceutical Research International, 699–706. https://doi.org/10.9734/jpri/2021/v33i59a34321
American Diabetes Association. (2022). Standards of Medical Care in Diabetes - Abridged for Primary Care Providers. Clinical Diabetes, 40(1), 10–38. https://doi.org/10.2337/cd22-as01
Annani-Akollor, M. E., Addai-Mensah, O., Fondjo, L. A., Sallah, L., Owiredu, E.-W., Acheampong, E., & Akamugri, S. (2019). Predominant Complications of Type 2 Diabetes in Kumasi: A 4-Year Retrospective Cross-Sectional Study at a Teaching Hospital in Ghana. Medicina, 55(5), 125. https://doi.org/10.3390/medicina55050125
Asher, G. N., Corbett, A. H., & Hawke, R. L. (2017). Common Herbal Dietary Supplement-Drug Interactions. American Family Physician, 96(2), 101–107.
Chen, J. Y., Ma, Q., Chen, H., & Yermilov, I. (2012). New Bundled World: Quality of Care and Readmission in Diabetes Patients. Journal of Diabetes Science and Technology, 6(3), 563–571. https://doi.org/10.1177/193229681200600311
Claire L Preston. (2015). Stockley’s Drug Interactions Pocket Companion.
Dryden, M., Baguneid, M., Eckmann, C., Corman, S., Stephens, J., Solem, C., Li, J., Charbonneau, C., Baillon-Plot, N., & Haider, S. (2015). Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections. Clinical Microbiology and Infection, 21, S27–S32. https://doi.org/10.1016/j.cmi.2015.03.024
Dungan, K. M. (2012). The Effect of Diabetes on Hospital Readmissions. Journal of Diabetes Science and Technology, 6(5), 1045–1052. https://doi.org/10.1177/193229681200600508
Endokrinologi Indonesia PEDOMAN PENGELOLAAN DAN PENCEGAHAN DIABETES MELITUS TIPE, P. (n.d.). PEDOMAN PENGELOLAAN DAN PENCEGAHAN DIABETES MELITUS TIPE 2 DEWASA DI INDONESIA-2021 PERKENI i Penerbit PB. PERKENI.
Enomoto, L. M., Shrestha, D. P., Rosenthal, M. B., Hollenbeak, C. S., & Gabbay, R. A. (2017). Risk factors associated with 30-day readmission and length of stay in patients with type 2 diabetes. Journal of Diabetes and Its Complications, 31(1), 122–127. https://doi.org/10.1016/j.jdiacomp.2016.10.021
Fullerton, B., Siebenhofer, A., Jeitler, K., Horvath, K., Semlitsch, T., Berghold, A., & Gerlach, F. M. (2018). Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD013228
Furqani, W. H., Zazuli, Z., Nadhif, N., Saidah, S., Abdulah, R., & Lestari, K. (2015). Drug Related Problems in the Management of Chronic Kidney Disease with Coronary Artery Disease. Indonesian Journal of Clinical Pharmacy, 4(2), 141–150. https://doi.org/10.15416/ijcp.2015.4.2.141
Fusco, S., Fusco, S., Cariati, D., Schepisi, R., Ganzetti, R., Sestili, M., David, S., Ferrara, L., Gatto, M. L., Vena, S., Corsonello, A., & Corica, F. (2015). Management of oral drug therapy in elderly patients with dysphagia.
Hamilton, H. J., Gallagher, P. F., & O’Mahony, D. (2009). Inappropriate prescribing and adverse drug events in older people. BMC Geriatrics, 9(1), 5. https://doi.org/10.1186/1471-2318-9-5
Harreiter, J., & Roden, M. (2019). Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2019). Wiener Klinische Wochenschrift, 131(S1), 6–15. https://doi.org/10.1007/s00508-019-1450-4
Hoel, R. W., Giddings Connolly, R. M., & Takahashi, P. Y. (2021). Polypharmacy Management in Older Patients. Mayo Clinic Proceedings, 96(1), 242–256. https://doi.org/10.1016/j.mayocp.2020.06.012
Huang, D., Xie, L., & Qiu, Y. (2015). Analysis of Factors Affecting the Length of Hospital Stay for Patients with Diabetes. Experimental and Clinical Endocrinology & Diabetes, 124(01), 5–10. https://doi.org/10.1055/s-0035-1565059
Hubbard, R. E., Peel, N. M., Scott, I. A., Martin, J. H., Smith, A., Pillans, P. I., Poudel, A., & Gray, L. C. (2015). Polypharmacy among inpatients aged 70 years or older in Australia. Medical Journal of Australia, 202(7), 373–377. https://doi.org/10.5694/mja13.00172
International Diabetes Federation (IDF) 9th Atlas. (2019). International Diabetes Federation. https://diabetesatlas.org/atlas/ninth-edition/
International Diabetes Federation. (2021). IDF Diabetes Atlas, 10th edn.
Joddy, R., Putra, S., Achmad, A., & Rachma, H. (n.d.). PHARMACEUTICAL JOURNAL OF INDONESIA Kejadian Efek Samping Potensial Terapi Obat Anti Diabetes Pasien Diabetes Melitus Berdasarkan Algoritma Naranjo. In PHARMACEUTICAL JOURNAL OF INDONESIA (Vol. 2017, Issue 2). http://.pji.ub.ac.id
Jonathan, K., & Natalia Mulyani Soetedjo, N. (n.d.). Nanny Natalia Mulyani Soetedjo. Pattern of Oral Antidiabetics Use in Type 2 Diabetes Mellitus Patients in Department of Internal Medicine.
Koubaity, M., Lelubre, M., Sansterre, G., Amighi, K., & de Vriese, C. (2019). Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies. International Journal of Clinical Pharmacy, 41(1), 244–250. https://doi.org/10.1007/s11096-018-0773-y
Linkeviciute-Ulinskiene, D., Kaceniene, A., Dulskas, A., Patasius, A., Zabuliene, L., & Smailyte, G. (2020). Increased Mortality Risk in People with Type 2 Diabetes Mellitus in Lithuania. International Journal of Environmental Research and Public Health, 17(18), 6870. https://doi.org/10.3390/ijerph17186870
Lipska, K. J., Krumholz, H., Soones, T., & Lee, S. J. (2016). Polypharmacy in the Aging Patient. JAMA, 315(10), 1034. https://doi.org/10.1001/jama.2016.0299
Madsen, K. S., Chi, Y., Metzendorf, M. I., Richter, B., & Hemmingsen, B. (2019). Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. In Cochrane Database of Systematic Reviews (Vol. 2019, Issue 12). John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD008558.pub2
Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatrics, 17(1), 230. https://doi.org/10.1186/s12877-017-0621-2
Mengesha, A. Y. (2007). Hypertension and related risk factors in type 2 diabetes mellitus (DM) patients in Gaborone City Council (GCC) clinics, Gaborone, Botswana. African Health Sciences, 7(4), 244–245.
Michelle, H. S. (2011). Management of dysphagia in stroke patients. Nursing Older People, 23(3), 21–24. https://doi.org/10.7748/nop2011.04.23.3.21.c8420
Mortazavi, S. S., Shati, M., Keshtkar, A., Malakouti, S. K., Bazargan, M., & Assari, S. (2016). Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open, 6(3), e010989. https://doi.org/10.1136/bmjopen-2015-010989
Naples, J. G., Hanlon, J. T., Schmader, K. E., & Semla, T. P. (2016). Recent Literature on Medication Errors and Adverse Drug Events in Older Adults. Journal of the American Geriatrics Society, 64(2), 401–408. https://doi.org/10.1111/jgs.13922
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009). Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy. Diabetes Care, 32(1), 193–203. https://doi.org/10.2337/dc08-9025
Noale, M., Veronese, N., Cavallo Perin, P., Pilotto, A., Tiengo, A., Crepaldi, G., & Maggi, S. (2016). Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment. Acta Diabetologica, 53(2), 323–330. https://doi.org/10.1007/s00592-015-0790-4
Raval, A. D., Zhou, S., Wei, W., Bhattacharjee, S., Miao, R., & Sambamoorthi, U. (2015). 30-Day Readmission Among Elderly Medicare Beneficiaries with Type 2 Diabetes. Population Health Management, 18(4), 256–264. https://doi.org/10.1089/pop.2014.0116
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., Shaw, J. E., Bright, D., & Williams, R. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice, 157, 107843. https://doi.org/10.1016/j.diabres.2019.107843
Salvi, F., Marchetti, A., D’Angelo, F., Boemi, M., Lattanzio, F., & Cherubini, A. (2012). Adverse Drug Events as a Cause of Hospitalization in Older Adults. Drug Safety, 35(S1), 29–45. https://doi.org/10.1007/BF03319101
Setacci C, Sirignano A Ricci G, Spagnolo AG, Pugliese F, & Speziale F. (2015). A new ethical and medico-legal issue: vascular surgery and the postoperative cognitive dysfunction. J Cardiovasc Surg (Torino). . 56(4), 607–615. https://pubmed.ncbi.nlm.nih.gov/25216219/
Soeatmadji, D. W., Rosandi, R., Saraswati, M. R., Sibarani, R. P., & Tarigan, W. O. (2023). Clinicodemographic Profile and Outcomes of Type 2 Diabetes Mellitus in the Indonesian Cohort of DISCOVER: A 3-Year Prospective Cohort Study. Journal of the ASEAN Federation of Endocrine Societies, 38(1), 68–74. https://doi.org/10.15605/jafes.038.01.10
Sutkowska, E., Fortuna, P., Wisniewski, J., Sutkowska, K., Hodurek, P., Gamian, A., & Kaluza, B. (2021). Low metformin dose and its therapeutic serum concentration in prediabetes. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-91174-7
Tharanon, V., Putthipokin, K., & Sakthong, P. (2022). Drug-related problems identified during pharmaceutical care interventions in an intensive care unit at a tertiary university hospital. SAGE Open Medicine, 10, 205031212210908. https://doi.org/10.1177/20503121221090881
Zhao, Q., Li, H., Ni, Q., Dai, Y., Zheng, Q., Wang, Y., Ke, T., Li, L., Zhao, D., Dong, Q., Ji, B., Shi, J., Peng, Y., Zhang, Y., Xu, F., & Wang, W. (2022). Follow‐up frequency and clinical outcomes in patients with type 2 diabetes: A prospective analysis based on multicenter real‐world data. Journal of Diabetes, 14(5), 306–314. https://doi.org/10.1111/1753-0407.13271
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Okky Intan Mawarni, Rina Herowati, Samuel Budi Harsono
This work is licensed under a Creative Commons Attribution 4.0 International License.
